Company: TXG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001770787-25-000032
Chunk: 3

Company: 10x Genomics, Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
380)Deferred revenue347 2,120 Accrued expenses and other current liabilities4,329 (12,674)Operating lease liability(2,631)(2,961)Other noncurrent liabilities360 249 Net cash provided by (used in) operating activities34,351 (15,725)Investing activities:Purchases of property and equipment(1,893)(2,910)Proceeds from sales of marketable securities— 568 Proceeds from maturities of marketable securities— 12,974 Net cash provided by (used in) investing activities(1,893)10,632 Financing activities:Issuance of common stock from exercise of stock options and employee stock purchase plan purchases422 1,638 Net cash provided by financing activities422 1,638 Effect of exchange rates changes on cash, cash equivalents114 (48)Net increase (decrease) in cash and cash equivalents32,994 (3,503)Cash, cash equivalents, and restricted cash at beginning of period344,067 359,284 Cash, cash equivalents, and restricted cash at end of period$377,061 $355,781 Supplemental disclosures of cash flow information:Cash paid for taxes$462 $961 Noncash investing and financing activities:Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities$398 $1,899 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Table of Contents10x Genomics, Inc.Notes to Unaudited Condensed Consolidated Financial Statements

o

1.    Description of Business and Basis of Presentation

Organization and Description of Business10x Genomics, Inc. (the “Company”) is a life sciences technology company focused on building innovative products and solutions to interrogate, understand and master biological systems at resolution and scale that matches the complexity of biology. The Company’s integrated solutions include the Company’s Chromium instruments and the Company's Visium CytAssist and Xenium Analyzer, which the Company refers to as “Spatial instruments,” and the Company’s proprietary microfluidic chips, slides, reagents and other consumables for the Company’s Chromium, Visium and Xenium solutions, which the Company refers to as “consumables.” The Company bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. The Company was incorporated in the state of Delaware